VA Funds $3.1M Pilot: Cold Exposure Protocol for Veteran PTSD and Chronic Pain
The Department of Veterans Affairs is funding a clinical trial testing structured cold water immersion as an adjunct therapy for veterans with comorbid PTSD and chronic pain — the first VA-funded cold exposure study.
The Study
The VA's Rehabilitation Research and Development Service has funded a $3.1 million pilot randomized controlled trial at the VA Puget Sound Health Care System. The study tests whether structured cold water immersion (CWI) can improve outcomes for veterans with comorbid PTSD and chronic musculoskeletal pain — a combination affecting an estimated 35% of post-9/11 veterans.
This is the first time the VA has funded a clinical trial specifically examining cold exposure as a therapeutic intervention.
The Protocol
Participants (n=120) will be randomized to one of three arms:
Structured CWI + Standard Care: Progressive cold water immersion (starting at 15°C, progressing to 10°C over 8 weeks), 3 sessions per week, each 11 minutes, supervised by trained facilitators. Combined with standard PTSD and pain management.
Warm Water Immersion + Standard Care: Same frequency and duration as CWI, but in thermoneutral water (36°C). Controls for the social, attentional, and time-out-of-routine components of the protocol.
Standard Care Alone: Treatment as usual — medication, psychotherapy, physical therapy.
Primary outcomes: PCL-5 (PTSD symptom severity), BPI (Brief Pain Inventory), and HRV as a biomarker of autonomic regulation. Secondary outcomes include sleep quality, inflammatory markers (IL-6, TNF-α, CRP), and treatment engagement.
Why This Matters
The veteran population has a unique relationship with cold exposure:
- Many veterans have prior experience with cold stress from military training
- The combination of PTSD and chronic pain is extremely common and extremely difficult to treat — each condition exacerbates the other
- Current pharmacological treatments (opioids for pain, SSRIs for PTSD) have limited efficacy and significant side effect and addiction risks
- Cold exposure targets autonomic dysregulation — the shared mechanism underlying both conditions
The theoretical basis draws from both stress inoculation training (familiar to military populations) and Polyvagal Theory (cold as a vagal toning tool that improves autonomic flexibility).
Implications
If the trial shows positive results, it could:
- Establish cold exposure as an evidence-based adjunct in VA treatment protocols
- Provide a low-cost, non-pharmacological option for the PTSD-pain comorbidity
- Generate the rigorous clinical data needed for cold exposure to move from "wellness trend" to recognized therapeutic modality
- Inform design of future cold exposure interventions (including dry cold systems) for clinical populations
The VA funding cold exposure research is a signal: the institution responsible for treating the most treatment-resistant population is looking beyond pharmaceuticals.